Cargando…

Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet

Microalgae are attracting attention as a next-generation alternative source of protein and essential fatty acids that do not consume large amounts of water or land. Chaetoceros gracilis (C. gracilis)—a marine microalga—is rich in proteins, fucoxanthin, and eicosapentaenoic acid (EPA). Growing eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirouchi, Bungo, Kawahara, Yuri, Kutsuna, Yuka, Higuchi, Mina, Okumura, Mai, Mitsuta, Sarasa, Nagao, Norio, Tanaka, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051878/
https://www.ncbi.nlm.nih.gov/pubmed/36984876
http://dx.doi.org/10.3390/metabo13030436
_version_ 1785014996860665856
author Shirouchi, Bungo
Kawahara, Yuri
Kutsuna, Yuka
Higuchi, Mina
Okumura, Mai
Mitsuta, Sarasa
Nagao, Norio
Tanaka, Kazunari
author_facet Shirouchi, Bungo
Kawahara, Yuri
Kutsuna, Yuka
Higuchi, Mina
Okumura, Mai
Mitsuta, Sarasa
Nagao, Norio
Tanaka, Kazunari
author_sort Shirouchi, Bungo
collection PubMed
description Microalgae are attracting attention as a next-generation alternative source of protein and essential fatty acids that do not consume large amounts of water or land. Chaetoceros gracilis (C. gracilis)—a marine microalga—is rich in proteins, fucoxanthin, and eicosapentaenoic acid (EPA). Growing evidence indicates that dietary fucoxanthin and EPA have beneficial effects in humans. However, none of these studies have shown that dietary C. gracilis has beneficial effects in mammals. In this study, we investigated the effects of dietary C. gracilis on lipid abnormalities in Sprague-Dawley rats fed a high-sucrose cholesterol-containing diet. Dried C. gracilis was added to the control diet at a final dose of 2 or 5% (w/w). After four weeks, the soleus muscle weights were found to be dose-responsive to C. gracilis and showed a tendency to increase. The hepatic triglyceride and total cholesterol levels were significantly reduced by C. gracilis feeding compared to those in the control group. The activities of FAS and G6PDH, which are related to fatty acid de novo synthesis, were found to be dose-responsive to C. gracilis and tended to decrease. The hepatic glycerol content was also significantly decreased by C. gracilis feeding, and the serum HDL cholesterol levels were significantly increased, whereas the serum levels of cholesterol absorption markers (i.e., campesterol and β-sitosterol) and the hepatic mRNA levels of Scarb1 were significantly decreased. Water-soluble metabolite analysis showed that the muscular contents of several amino acids, including leucine, were significantly increased by C. gracilis feeding. The tendency toward an increase in the weight of the soleus muscle as a result of C. gracilis feeding may be due to the enhancement of muscle protein synthesis centered on leucine. Collectively, these results show that the oral administration of C. gracilis alleviates hepatic lipid accumulation in rats fed a high-sucrose and cholesterol-containing diet, indicating the potential use of C. gracilis as a food resource.
format Online
Article
Text
id pubmed-10051878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100518782023-03-30 Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet Shirouchi, Bungo Kawahara, Yuri Kutsuna, Yuka Higuchi, Mina Okumura, Mai Mitsuta, Sarasa Nagao, Norio Tanaka, Kazunari Metabolites Article Microalgae are attracting attention as a next-generation alternative source of protein and essential fatty acids that do not consume large amounts of water or land. Chaetoceros gracilis (C. gracilis)—a marine microalga—is rich in proteins, fucoxanthin, and eicosapentaenoic acid (EPA). Growing evidence indicates that dietary fucoxanthin and EPA have beneficial effects in humans. However, none of these studies have shown that dietary C. gracilis has beneficial effects in mammals. In this study, we investigated the effects of dietary C. gracilis on lipid abnormalities in Sprague-Dawley rats fed a high-sucrose cholesterol-containing diet. Dried C. gracilis was added to the control diet at a final dose of 2 or 5% (w/w). After four weeks, the soleus muscle weights were found to be dose-responsive to C. gracilis and showed a tendency to increase. The hepatic triglyceride and total cholesterol levels were significantly reduced by C. gracilis feeding compared to those in the control group. The activities of FAS and G6PDH, which are related to fatty acid de novo synthesis, were found to be dose-responsive to C. gracilis and tended to decrease. The hepatic glycerol content was also significantly decreased by C. gracilis feeding, and the serum HDL cholesterol levels were significantly increased, whereas the serum levels of cholesterol absorption markers (i.e., campesterol and β-sitosterol) and the hepatic mRNA levels of Scarb1 were significantly decreased. Water-soluble metabolite analysis showed that the muscular contents of several amino acids, including leucine, were significantly increased by C. gracilis feeding. The tendency toward an increase in the weight of the soleus muscle as a result of C. gracilis feeding may be due to the enhancement of muscle protein synthesis centered on leucine. Collectively, these results show that the oral administration of C. gracilis alleviates hepatic lipid accumulation in rats fed a high-sucrose and cholesterol-containing diet, indicating the potential use of C. gracilis as a food resource. MDPI 2023-03-16 /pmc/articles/PMC10051878/ /pubmed/36984876 http://dx.doi.org/10.3390/metabo13030436 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shirouchi, Bungo
Kawahara, Yuri
Kutsuna, Yuka
Higuchi, Mina
Okumura, Mai
Mitsuta, Sarasa
Nagao, Norio
Tanaka, Kazunari
Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title_full Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title_fullStr Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title_full_unstemmed Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title_short Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
title_sort oral administration of chaetoceros gracilis—a marine microalga—alleviates hepatic lipid accumulation in rats fed a high-sucrose and cholesterol-containing diet
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051878/
https://www.ncbi.nlm.nih.gov/pubmed/36984876
http://dx.doi.org/10.3390/metabo13030436
work_keys_str_mv AT shirouchibungo oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT kawaharayuri oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT kutsunayuka oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT higuchimina oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT okumuramai oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT mitsutasarasa oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT nagaonorio oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet
AT tanakakazunari oraladministrationofchaetocerosgracilisamarinemicroalgaalleviateshepaticlipidaccumulationinratsfedahighsucroseandcholesterolcontainingdiet